arrow
返回
J

Jennifer A. Woyach

The Ohio State University

61H指数
604论文数
1.8W被引数
收录论文 137
发表时间
Hodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia化疗初治慢性淋巴细胞白血病患者中霍奇金淋巴瘤的转化
err2026-09-26
err0
errOAAI
errPaul J. Hampel; Ying Huang; John N. Allan; Seema A. Bhat; David Bond; Danielle M. Brander; John C. Byrd; Julio C. Chavez; Elise Chong; Alexey Danilov; Matthew S. Davids; Kaitlyn Dvorak-Kornaus; Hannah Freedman; Nikita Malakhov; Matthew Matasar; Cecelia Miller; Sarah Miller; Zulfa Omer; Sameer A. Parikh; Erin M. Parry; Kari G. Rabe; Phil Raess; Manoj Rai; Joanna M. Rhodes; Kerry A. Rogers; Aditi Saha; Jake Schade; Geoffrey Shouse; Stephen Spurgeon; Deborah Stephens; Yucai Wang; Jennifer A. Woyach; Max Yano; Adam S. Kittai
err分享
err收藏
err分享
err收藏
Outcomes of patients with chronic lymphocytic leukemia discontinuing covalent Bruton tyrosine kinase inhibitors due to adverse events慢性淋巴细胞白血病患者因不良事件停用共价布鲁顿酪氨酸激酶抑制剂的临床结局
errLeukemia
IF13.4
err2026-06-25
err0
PREAI
errAnthony G. Mansour; Ying Huang; J. Phillip Pemberton; Aseel Alsouqi; Adam S. Kittai; John C. Byrd; Michael R. Grever; Cecelia Miller; Gerard Lozanski; Tracy Wiczer; Jordan Lundberg; Lindsay Rosen; Caitlyn Crawford; Tyler Everhart; Mollie Moran; Margaret Lucas; Swetha Hinton; Cara Grantier; Corinne Hoffman; Mark Reid; Kerry A. Rogers; Seema A. Bhat; Jennifer A. Woyach
err分享
err收藏
Recurrent Genomic Alterations in BCRi-Experienced CLL Patients Treated With Venetoclax: Extended Phase 2 Follow-Up接受维奈克拉治疗的BCRi经治CLL患者中复发性基因组改变:扩展的2期随访研究
err2026-04-08
err0
errOAAI
errJennifer A. Woyach; Relja Popovic; Emily L. Rossi; Sanjana Singh; Toshihiko Oki; Tanya S. Rosenberg; Chen Qian; Michael Moran; Zihuan Liu; Michelle Boyer; Jeffrey Jones; Richard R. Furman; William Wierda; Jason Gotlib; Stephen J. Schuster; Brenda Chyla; Matthew S. Davids
err分享
err收藏
Final phase 2 study results of acalabrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemiaAcalabrutinib在初治及复发/难治性慢性淋巴细胞白血病中的最终II期研究结果
err2026-04-02
err0
errOAAI
errRichard R. Furman; William G. Wierda; Piers E.M. Patten; Jorge M. Chaves; Jennifer R. Brown; Talha Munir; Peter Martin; Farrukh T. Awan; Deborah M. Stephens; Paolo Ghia; Jacqueline C. Barrientos; Krish Patel; Jennifer A. Woyach; Marianne de Borja; Min-Hui Wang; Nitin Jain; Susan M. O’Brien; John C. Byrd
err分享
err收藏
Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma, Version 2.2026 Featured Updates to the NCCN GuidelinesNCCN Guidelines® 要点:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤,版本 2.2026
err2026-03-01
err3
PREAI
errWierda, William G.; Brown, Jennifer; Abramson, Jeremy S.; Awan, Farrukh; Bociek, Greg; Boyer, Daniel; Cortese, Matthew; Cripe, Larry; D'Angelo, Christopher; Darnell, Elijah; Davis, Randall S.; Eradat, Herbert; Esteghamat, Naseem; Fitzgerald, Lindsey; Fletcher, Christopher D.; Gaballa, Sameh; Huntington, Scott; Kahl, Brad; Kamdar, Manali; Kipps, Thomas J.; Ma, Shuo; Mosse, Claudio A.; Nakhoda, Shazia; Parikh, Sameer A.; Riedell, Peter; Schorr, Andrew; Schuster, Stephen; Seshadri, Madhav; Shanafelt, Tait; Siddiqi, Tanya; Sitlinger, Andrea; Thompson, Meghan; Ujjani, Chaitra; Wagner-Johnston, Nina; Woyach, Jennifer A.; Dwyer, Mary; Sundar, Hema
err分享
err收藏
Pirtobrutinib, a Highly Selective, Non-covalent (Reversible) BTKi in R/R Marginal Zone Lymphoma: Phase 1/2 BRUIN StudyPirtobrutinib,R/R边缘区淋巴瘤中的高选择性,非共价 (可逆) BTKi: 1/2期布鲁因研究
err2026-01-20
err0
errOAAI
errKrish Patel; Julie Vose; Sunita D. Nasta; Jennifer R. Brown; Kami Maddocks; Jennifer Woyach; Nirav N. Shah; Bita Fakhri; Benoit Tessoulin; Shuo Ma; Deepa Jagadeesh; Ewa Lech-Maranda; Catherine C. Coombs; Manish R. Patel; Joanna M. Rhodes; Chaitra Ujjani; Marc S. Hoffmann; Chan Y. Cheah; Talha Munir; David Lewis
err分享
err收藏
A Phase I Study of Combination Duvelisib and Nivolumab in Patients With Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, and Richter Transformation一项关于Duvelisib与Nivolumab联合治疗弥漫性大B细胞淋巴瘤、转化性滤泡性淋巴瘤和Richter转化的I期研究
err2025-12-01
err0
PREAI
errAlsouqi, Aseel; Huang, Ying; Christian, Beth; Reneau, John; Bhat, Seema A.; Brammer, Jonathan; Sawalha, Yazeed; Baiocchi, Robert A.; Grever, Michael; Rogers, Kerry A.; Reeser, Julie; Smith, Amy; Samorodnitsky, Eric; Roychowdhury, Sameek; Maddocks, Kami; Woyach, Jennifer A.; Bond, David
err分享
err收藏
Genomic Determinants of Response and Resistance to Pirtobrutinib in Relapsed/Refractory Chronic Lymphocytic LeukemiaPirtobrutinib对复发/难治性慢性淋巴细胞白血病的反应和耐药性的基因组决定因素
errBlood
IF23.1
err2025-10-10
err0
errOAAI
errJennifer R. Brown; Bastien Nguyen; Sai Prasad Desikan; Helen Won; Shady I. Tantawy; Samuel C. McNeely; Narasimha Marella; Hetal S. Randeria; Lauren M. Hanson; Andrew Parker; Salomé Calado Botelho; Jennifer A. Woyach; Krish Patel; Constantine S. Tam; Toby A. Eyre; Chan Y. Cheah; Nirav N. Shah; Paolo Ghia; Wojciech Jurczak; Minna Balbas; Binoj Nair; Paolo Abada; Chunxiao Wang; Denise Wang; Lindsey E. Roeker; Varsha Gandhi; William G. Wierda
err分享
err收藏
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study携带t(14;19)易位的慢性淋巴细胞白血病患者临床及转录组学特征:一项ERIC研究
errLeukemia
IF13.4
err2025-09-19
err0
errOAAI
errAndrea Visentin; Enrico Gaffo; Moritz Fürstenau; Kerry A. Rogers; Baliakas Panagiotis; Chenghua Cui; Cecelia Miller; Claudia Haferlach; Karla Plevova; David Oscier; Zadie Davis; Florence Nguyen-Khac; Eleonora Roncaglia; Gian Matteo Rigolin; Anastasia Athanasiadou; Fanny Baran-Marszak; Alberto Valiente; Maria José Terol; Pau Abrisqueta; Blanca Espinet; Anna Puiggros; Annalisa Martines; Laura Bonaldi; Francesca Romana Mauro; Lydia Scarfò; Thomas Chatzikonstantinou; Eugen Tausch; Karl-Anton Kreuzer; Arnon Kater; Francesc Bosch; Michael Doubek; Panagiotis Panagiotidis; Olga Kalashnikova; Federica Frezzato; Giulia Calabretto; Valeria Ruocco; Silvia Orsi; Alessandro Cellini; Francesco Angotzi; Andrea Serafin; Shuhua Yi; Barbara Eichhorst; Jennifer A. Woyach; Antonio Cuneo; Paolo Ghia; Kostas Stamatopoulos; Livio Trentin; Stefania Bortoluzzi
err分享
err收藏
Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice慢性淋巴细胞白血病对靶向疗法的耐药性:临床和诊断实践中的现状与展望
errLeukemia
IF13.4
err2025-06-24
err0
errOAAI
errPiers Blombery; Thomas Chatzikonstantinou; Marina Gerousi; Richard Rosenquist; Gianluca Gaidano; Sarka Pospisilova; Andrew W. Roberts; Richard W. Birkinshaw; Davide Rossi; Lydia Scarfo; John F. Seymour; Stephan Stilgenbauer; Adrian Wiestner; Jennifer A. Woyach; Jennifer R. Brown; Paolo Ghia; Kostas Stamatopoulos
err分享
err收藏
Clinical Practice Recommendations on the Role Of Allogeneic Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy in Patients With Chronic Lymphocytic Leukemia on Behalf of the American Society for Transplantation and Cellular Therapy代表美国移植与细胞治疗学会发布的关于异基因造血细胞移植和嵌合抗原受体T细胞疗法在慢性淋巴细胞白血病患者中作用的临床实践建议
err2025-06-01
err0
errOAAI
errMohamed A. Kharfan-Dabaja; Ambuj Kumar; Javier Pinilla-Ibarz; Jennifer R. Brown; Mazyar Shadman; Farrukh T. Awan; Saad S. Kenderian; Tanya Siddiqi; Jeremy S. Abramson; Taha Al-Juhaishi; Danielle M. Brander; Catherine C. Coombs; Richard R. Furman; Nitin Jain; Nadia Khan; Nakhle S. Saba; Jennifer M. Collins; Amer Beitinjaneh; Deborah M. Stephens; Jennifer Woyach; Mehdi Hamadani
err分享
err收藏
Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TNSharman, J.P.; Egyed, M.; Jurczak, W.; Skarbnik, A.; Patel, K.; Flinn, I.W.; Kamdar, M.; Munir, T.; Walewska, R.; Hughes, M.; et al. Acalabrutinib-obinutuzumab在ELEVATE-TN的6年随访中,与化疗免疫疗法相比,提高了初治CLL患者的生存率。Blood 2025, 146, 1276–1285. [Google Scholar] [CrossRef]
errBlood
IF23.1
err2025-04-11
err0
errOAAI
errJeff P. Sharman; Miklos Egyed; Wojciech Jurczak; Alan Skarbnik; Krish Patel; Ian W. Flinn; Manali Kamdar; Talha Munir; Renata Walewska; Marie Hughes; Laura Maria Fogliatto; Yair Herishanu; Versha Banerji; George Follows; Patricia Walker; Paolo Ghia; Ann Janssens; John C. Byrd; Emmanuelle Ferrant; Alessandra Ferrajoli; William G. Wierda; Catherine Wangui Wachira; Batul T. Suterwala; Paulo Miranda; Veerendra Munugalavadla; Chuan-Chuan Wun; Jennifer A. Woyach
err分享
err收藏
Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL未接受过既往化疗免疫疗法治疗的Richter转化CLL患者的结局
err2025-02-20
err1
errOAAI
errKittai, Adam S.; Huang, Ying; Miller, Sarah; Allan, John N.; Bhat, Seema A.; Bond, David A.; Brander, Danielle M.; Byrd, John C.; Chavez, Julio C.; Chong, Elise; Davids, Matthew S.; Danilov, Alexey V.; Ding, Wei; Dowling, Mark R.; Dvorak-Kornaus, Kaitlyn; Freedman, Hannah; Hampel, Paul J.; Ho, Carrie; Hwang, Steven R.; Islam, Prioty; Malakhov, Nikita; Matasar, Matthew; Miller, Cecelia; Omer, Zulfa; Parikh, Sameer A.; Parry, Erin; Rabe, Kari G.; Raess, Philipp W.; Rai, Manoj; Roeker, Lindsey; Rhodes, Joanna; Rogers, Kerry A.; Saha, Aditi; Schade, Jake; Scott, Hamish W.; Shadman, Mazyar; Shouse, Geoffrey; Skarbnik, Alan; Spurgeon, Stephen; Stephens, Deborah M.; Thompson, Meghan C.; Thompson, Philip A.; Wang, Yucai; Yano, Max; Woyach, Jennifer A.
err分享
err收藏
Predictive ability of the Cancer and Aging Research Group chemotherapy toxicity calculator in hematologic malignancy
err2025-01-01
err1
PREAI
errRosko, Ashley E.; Huang, Ying; Wall, Sarah A.; Mims, Alice; Woyach, Jennifer; Presley, Carolyn; Williams, Nicole O.; Stevens, Erin; Han, Claire J.; Von Ah, Diane; Islam, Nowshin; Krok-Schoen, Jessica L.; Burd, Christin E.; Naughton, Michelle J.
err分享
err收藏
Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naive chronic lymphocytic leukemia (Dec, 10.1038/s41375-024-02487-1, 2024)
errLEUKEMIA
IF13.4
err2024-12-03
err0
errOAAI
errSharman, Jeff P.; Egyed, Miklos; Jurczak, Wojciech; Skarbnik, Alan; Pagel, John M.; Flinn, Ian W.; Kamdar, Manali; Munir, Talha; Walewska, Renata; Corbett, Gillian; Fogliatto, Laura Maria; Herishanu, Yair; Banerji, Versha; Coutre, Steven; Follows, George; Walker, Patricia; Karlsson, Karin; Ghia, Paolo; Janssens, Ann; Cymbalista, Florence; Woyach, Jennifer A.; Ferrant, Emmanuelle; Wierda, William G.; Munugalavadla, Veerendra; Yu, Ting; Wang, Min Hui; Byrd, John C.
err分享
err收藏
Protein Degrader WH25244 Eliminates Venetoclax Resistance Factors: Mutant or Hyperphosphorylated BCL2, and BCL-XL蛋白降解剂WH25244消除Venetoclax耐药因子:突变型或过度磷酸化BCL2,以及BCL-XL
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errRohena, Daisy Y. Diaz; Mitchell, Andrew D.; Wang, Jing; Chamberlain, Stephanie; Liu, Chaomei; Sanchez II, John R.; Williams, Charmelle D.; Wathan, Trisha K.; Slawin, Bailey; Bowman, Kevin; Yuan, Yaxia; Zhang, Peiyi; Hu, Wanyi; Zheng, Guangrong; Wierda, William G.; Jain, Nitin; Davids, Matthew S.; Zhou, Daohong; Woyach, Jennifer A.; Sampath, Deepa
err分享
err收藏